Dawson L

ORCID: 0000-0002-6879-6602 · 3 papers in corpus
2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30120739

Ovarian cancer (OC) is Canada's third most common gynecological cancer, with an estimated 3000 new cases and 1950 deaths projected in 2022. No effective screening has been found to identify OC, especially the most common subtype, high-grade…

2023
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol30100678

Pathogenic variants (PVs) in BRCA1 and BRCA2 increase the lifetime risks of breast and ovarian cancer. Guidelines recommend breast screening (magnetic resonance imaging (MRI) and mammogram) or risk-reducing mastectomy (RRM) and salpingo-oop…

2022
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol29070368

Individuals with proven hereditary cancer syndrome (HCS) such as BRCA1 and BRCA2 have elevated rates of ovarian, breast, and other cancers. If these high-risk people can be identified before a cancer is diagnosed, risk-reducing intervention…